Stem cell therapy: medical advance or moral challenge?

被引:0
|
作者
Lachmann, PJ [1 ]
机构
[1] Ctr Vet Sci, Microbial Immunol Grp, Cambridge CB3 0ES, England
关键词
stem cells; disease; moral;
D O I
10.1016/S1631-0691(02)01526-3
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
My professional lifetime has seen progress in the biomedical sciences that beggars belief. This has lead to astonishing advances in the ability to prevent and treat disease and, in the developed world at least, people live longer and healthier lives than ever before. Paradoxically, this has gone hand in hand with the growth of a vocal and influential anti-science lobby that not only rejects much modern science-but is also deeply suspicious of new medical interventions. The prospect of cell therapy in the near or middle future is their current target especially where the use of embryonic stem cells or of cell nuclear transfer techniques is concerned. The prospect of cell therapy is welcomed with enthusiasm by patients with genetic and degenerative diseases who hope to benefit from them. On the other hand the whole idea is regarded as repugnant by the anti-science lobby. While some of this opposition is essentially luddite in nature, there are some more persuasive arguments raised particularly to any research than uses embryonic or foetal materials. These arguments will be examined critically. The moral problems of denying the sick the hope of effective treatments have to be weighed against those seen in the development of such treatments. (This article is closely based on an already published paper. P. Lachmann, Stem cell research: why is it regarded as a threat? An investigation of the economic and ethical arguments made against research with human embryonic stem cells. EMBO Rep. 2 (3) (2001) 165-168).
引用
收藏
页码:1049 / 1051
页数:3
相关论文
共 50 条
  • [1] Stem cell-derived embryo models: moral advance or moral obfuscation?
    Gyngell, Christopher
    Lynch, Fiona
    Sawai, Tsutomu
    Savulescu, Julian
    JOURNAL OF MEDICAL ETHICS, 2024,
  • [2] Immunogenicity and Allogenicity: A Challenge of Stem Cell Therapy
    Dominique Charron
    Caroline Suberbielle-Boissel
    Reem Al-Daccak
    Journal of Cardiovascular Translational Research, 2009, 2
  • [3] Immunogenicity and Allogenicity: A Challenge of Stem Cell Therapy
    Charron, Dominique
    Suberbielle-Boissel, Caroline
    Al-Daccak, Reem
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2009, 2 (01) : 130 - 138
  • [4] The new challenge of stem cell: Brain tumour therapy
    Colleoni, F.
    Torrente, Y.
    CANCER LETTERS, 2008, 272 (01) : 1 - 11
  • [5] Stem cell challenge in cancer progression, oncology and therapy
    Alnasser, Sulaiman Mohammed
    GENE, 2022, 840
  • [6] Application of biomaterials to advance induced pluripotent stem cell research and therapy
    Tong, Zhixiang
    Solanki, Aniruddh
    Hamilos, Allison
    Levy, Oren
    Wen, Kendall
    Yin, Xiaolei
    Karp, Jeffrey M.
    EMBO JOURNAL, 2015, 34 (08): : 987 - 1008
  • [7] HOW DO WE ADVANCE STEM CELL GENE THERAPY IN JAPAN?
    Onodera, Masafumi
    JOURNAL OF GENE MEDICINE, 2009, 11 (12): : 1146 - 1146
  • [8] Tumor stem cell research - basis and challenge for diagnosis and therapy
    Karlic, Heidrun
    Herrmann, Harald
    Schulenburg, Axel
    Grunt, Thomas W.
    Laffer, Sylvia
    Mirkina, Irina
    Hubmann, Rainer
    Shehata, Medhat
    Marian, Brigitte
    Selzer, Edgar
    Pfeilstoecker, Michael
    Pittermann, Elisabeth
    Jaeger, Ulrich
    Pehamberger, Hubert
    Zielinski, Christoph
    Valent, Peter
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (13-14) : 423 - 436
  • [9] Skeletal stem-cell therapy: challenge meets opportunity
    Cheng, Weinan
    Huang, Jianming
    Li, Na
    Xu, Ren
    LANCET, 2024, 403 (10423): : 243 - 243
  • [10] The stem cell challenge
    Lanza, R
    Rosenthal, N
    SCIENTIFIC AMERICAN, 2004, 290 (06) : 92 - 99